|
humans |
152 |
|
adolescent |
115 |
|
male |
114 |
|
children |
111 |
|
female |
105 |
|
child |
104 |
|
covid-19 |
103 |
|
chinese |
94 |
|
hong kong |
90 |
|
child, preschool |
86 |
|
adult |
85 |
|
infant |
78 |
|
animals |
63 |
|
middle aged |
60 |
|
epidemiology |
57 |
|
hong kong - epidemiology |
56 |
|
sars-cov-2 |
45 |
|
interprofessional education |
44 |
|
pediatrics |
44 |
|
cells, cultured |
39 |
|
mice |
39 |
|
genetic predisposition to disease |
38 |
|
risk factors |
37 |
|
infant, newborn |
36 |
|
vaccine |
36 |
|
adolescents |
35 |
|
pediatric |
32 |
|
medical sciences |
31 |
|
prevalence |
31 |
|
health-related quality of life |
30 |
|
aged |
29 |
|
phenotype |
29 |
|
pregnancy |
29 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
mental health |
27 |
|
nasopharyngeal carcinoma |
27 |
|
cardiomyocytes |
26 |
|
chemicals and cas registry numbers |
26 |
|
china |
26 |
|
cohort studies |
26 |
|
cross-sectional studies |
26 |
|
treatment outcome |
26 |
|
case-control studies |
25 |
|
incidence |
25 |
|
magnetic resonance imaging |
25 |
|
prospective studies |
25 |
|
apoptosis |
24 |
|
child development |
24 |
|
genotype |
24 |
|
systemic lupus erythematosus |
24 |
|
asian continental ancestry group - genetics |
23 |
|
coronavirus |
23 |
|
genome-wide association study |
23 |
|
hospitalization |
23 |
|
mutation |
23 |
|
prognosis |
23 |
|
retrospective studies |
23 |
|
reverse transcriptase polymerase chain reaction |
23 |
|
sars |
23 |
|
signal transduction |
23 |
|
cytokines |
22 |
|
infants |
22 |
|
public health |
22 |
|
cell line |
21 |
|
embryonic stem cells |
21 |
|
meta-analysis |
21 |
|
physical activity |
21 |
|
polymorphism, single nucleotide - genetics |
21 |
|
rats |
21 |
|
safety |
21 |
|
school closure |
21 |
|
screen time |
21 |
|
base sequence |
20 |
|
bone marrow transplantation |
20 |
|
complications |
20 |
|
immunotherapy |
20 |
|
influenza |
20 |
|
reference values |
20 |
|
up-regulation |
20 |
|
amino acid sequence |
19 |
|
paediatrics |
19 |
|
polymorphism, genetic |
19 |
|
coronavac |
18 |
|
depression |
18 |
|
disease outbreaks - statistics & numerical data |
18 |
|
hepatocellular carcinoma |
18 |
|
inflammation |
18 |
|
influenza a virus, h1n1 subtype - immunology |
18 |
|
molecular sequence data |
18 |
|
sle |
18 |
|
time factors |
18 |
|
vaccination |
18 |
|
young adult |
18 |
|
animal tissue |
17 |
|
asthma |
17 |
|
magnetic resonance imaging - methods |
17 |
|
omicron |
17 |
|
perceived stress |
17 |
|
whole-exome sequencing |
17 |
|
adult learning principles |
16 |
|
alleles |
16 |
|
biology |
16 |
|
child psychosocial problems |
16 |
|
chinese children |
16 |
|
chromosome aberration |
16 |
|
collaborative practice |
16 |
|
cytokine |
16 |
|
disease models, animal |
16 |
|
evaluation |
16 |
|
genetics |
16 |
|
healthcare workers |
16 |
|
heterozygote |
16 |
|
home confinement |
16 |
|
hospital policies |
16 |
|
immunoglobulin |
16 |
|
influenza, human - epidemiology - immunology - virology |
16 |
|
low-income families |
16 |
|
psychological wellbeing |
16 |
|
systematic review |
16 |
|
vitamin d |
16 |
|
adolescence |
15 |
|
asia |
15 |
|
association |
15 |
|
autoimmunity |
15 |
|
child health |
15 |
|
child maltreatment |
15 |
|
congenital heart disease |
15 |
|
cord blood |
15 |
|
coronavirus disease 2019 |
15 |
|
diagnosis |
15 |
|
fatal outcome |
15 |
|
genome sequencing |
15 |
|
innate immunity |
15 |
|
latent class analysis |
15 |
|
mediation |
15 |
|
osteoporosis |
15 |
|
pandemic |
15 |
|
pandemics |
15 |
|
polymerase chain reaction |
15 |
|
population surveillance |
15 |
|
quality of life |
15 |
|
rare diseases |
15 |
|
risk assessment |
15 |
|
seroepidemiologic studies |
15 |
|
single nucleotide polymorphism |
15 |
|
stool |
15 |
|
acute disease |
14 |
|
age factors |
14 |
|
allergy |
14 |
|
antibodies, viral - blood |
14 |
|
anxiety |
14 |
|
asian |
14 |
|
asian continental ancestry group |
14 |
|
autophagy |
14 |
|
breastfeeding |
14 |
|
cluster analysis |
14 |
|
coronavirus infection |
14 |
|
epilepsy |
14 |
|
epstein-barr virus |
14 |
|
gene expression |
14 |
|
health outcomes |
14 |
|
immunity |
14 |
|
immunity, innate |
14 |
|
kawasaki disease |
14 |
|
obesity |
14 |
|
phylogeny |
14 |
|
qualitative |
14 |
|
sensitivity and specificity |
14 |
|
vaccine effectiveness |
14 |
|
antigens, cd - genetics |
13 |
|
cancer susceptibility genes |
13 |
|
cell adhesion molecules - genetics |
13 |
|
cell differentiation |
13 |
|
china - epidemiology |
13 |
|
cross protection |
13 |
|
developmental delay |
13 |
|
disease progression |
13 |
|
down syndrome |
13 |
|
early-age onset |
13 |
|
gene frequency |
13 |
|
hematopoietic stem cell transplantation |
13 |
|
hypoxia |
13 |
|
immunohistochemistry |
13 |
|
immunology |
13 |
|
immunophenotyping |
13 |
|
l-lactate dehydrogenase - blood |
13 |
|
leukemia |
13 |
|
lupus erythematosus, systemic - genetics |
13 |
|
lupus nephritis |
13 |
|
lymphocyte subsets |
13 |
|
models, biological |
13 |
|
mortality |
13 |
|
mst1r |
13 |
|
myocardial infarction |
13 |
|
neonates |
13 |
|
physical fitness |
13 |
|
rats, sprague-dawley |
13 |
|
severity of illness index |
13 |
|
viral load |
13 |
|
whole exome sequencing |
13 |
|
anorectal malformation |
12 |
|
asparaginase |
12 |
|
bmi |
12 |
|
bnt162b2 |
12 |
|
cardiac differentiation |
12 |
|
cognition |
12 |
|
convalescence |
12 |
|
cytokines - biosynthesis |
12 |
|
dendritic cells |
12 |
|
dna methylation |
12 |
|
efficacy |
12 |
|
electrophysiology |
12 |
|
ephrin-a2 - genetics |
12 |
|
exome sequencing |
12 |
|
false positive |
12 |
|
gene expression regulation |
12 |
|
hospitalization - statistics & numerical data |
12 |
|
human |
12 |
|
infection |
12 |
|
influenza, human - immunology - virology |
12 |
|
interferon |
12 |
|
lupus |
12 |
|
neutralization tests |
12 |
|
next-generation sequencing |
12 |
|
nk cells |
12 |
|
rna, messenger - metabolism |
12 |
|
sars-cov-2 rbd igg |
12 |
|
serology |
12 |
|
smoking cessation |
12 |
|
t cell response |
12 |
|
uhrf1bp1 |
12 |
|
wnt signaling pathway |
12 |
|
young adults |
12 |
|
algorithms |
11 |
|
analysis of variance |
11 |
|
antigens, cd3 - genetics |
11 |
|
antimicrobial resistance |
11 |
|
autoantibodies - blood |
11 |
|
cd247 |
11 |
|
childhood |
11 |
|
collagen |
11 |
|
cytotoxicity |
11 |
|
diffusion |
11 |
|
dna mutational analysis |
11 |
|
drug |
11 |
|
feces - virology |
11 |
|
gwas |
11 |
|
hepatoblastoma |
11 |
|
human embryonic stem cells |
11 |
|
hypersensitivity |
11 |
|
intellectual disability |
11 |
|
lupus erythematosus, systemic - enzymology - genetics |
11 |
|
lupus erythematosus, systemic - genetics - immunology |
11 |
|
mice, inbred c57bl |
11 |
|
mutation - genetics |
11 |
|
oxidative stress |
11 |
|
pilot projects |
11 |
|
proarrhythmias |
11 |
|
recurrence |
11 |
|
reproducibility of results |
11 |
|
seasons |
11 |
|
severe acute respiratory syndrome |
11 |
|
social support |
11 |
|
statistics & research methods |
11 |
|
stem cell |
11 |
|
t-lymphocytes, cytotoxic - immunology |
11 |
|
treatment |
11 |
|
γδ-t cells |
11 |
|
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
|
adenovirus |
10 |
|
age of onset |
10 |
|
all-cause pneumonia |
10 |
|
anaphylaxis |
10 |
|
antibodies, antinuclear - blood |
10 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
10 |
|
attention-deficit/hyperactivity disorder |
10 |
|
autism spectrum disorder |
10 |
|
bidirectional relationship |
10 |
|
birds |
10 |
|
brain microstructure |
10 |
|
child day care centers |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
cytokines - metabolism |
10 |
|
dead-box rna helicases - genetics - immunology - metabolism |
10 |
|
dendritic cells - immunology |
10 |
|
diagnosis, differential |
10 |
|
diffusion kurtosis imaging |
10 |
|
disease burden |
10 |
|
dose-response relationship, drug |
10 |
|
drug resistance |
10 |
|
embryonic stem cells - cytology |
10 |
|
epithelial cells - immunology - metabolism |
10 |
|
follow-up studies |
10 |
|
functional outcome |
10 |
|
genetic testing |
10 |
|
haplotypes |
10 |
|
heart |
10 |
|
herd immunity |
10 |
|
human leukocyte antigens |
10 |
|
immunodeficiency |
10 |
|
induced pluripotent stem cells |
10 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza virus |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - epidemiology - virology |
10 |
|
influenza, human - immunology - metabolism - virology |
10 |
|
influenza, human - mortality |
10 |
|
interferon regulatory factor-3 - metabolism |
10 |
|
interferon-gamma - metabolism |
10 |
|
interrupted time series analysis |
10 |
|
intracellular signaling peptides and proteins - genetics |
10 |
|
intracranial germ cell tumor |
10 |
|
janus kinases - immunology |
10 |
|
linkage disequilibrium |
10 |
|
macrophages - immunology |
10 |
|
macrophages - immunology - metabolism |
10 |
|
meningitis |
10 |
|
molecular tumour board |
10 |
|
mri |
10 |
|
multivariate analysis |
10 |
|
nerve tissue proteins - genetics |
10 |
|
neuroblastoma |
10 |
|
neurotoxicity |
10 |
|
nf-kappa b - metabolism |
10 |
|
p38 mitogen-activated protein kinases - metabolism |
10 |
|
paracrine communication - immunology |
10 |
|
parental stress |
10 |
|
patient admission - statistics and numerical data |
10 |
|
pneumococcal conjugate vaccines |
10 |
|
polymorphism, single nucleotide |
10 |
|
population-based electronic health records |
10 |
|
population-based study |
10 |
|
precision oncology |
10 |
|
prediction |
10 |
|
pulmonary alveoli - immunology - metabolism |
10 |
|
quality control |
10 |
|
questionnaires |
10 |
|
radiation therapy |
10 |
|
rare disease |
10 |
|
receptor, interferon alpha-beta - immunology |
10 |
|
respiratory tract infections - virology |
10 |
|
rna, small interfering - genetics |
10 |
|
rna, viral - metabolism |
10 |
|
sequence-directed therapy |
10 |
|
syndrome |
10 |
|
t-lymphocytes |
10 |
|
telomere |
10 |
|
toll-like receptor 3 - metabolism |
10 |
|
transplantation |
10 |
|
validation |
10 |
|
age-stratified |
9 |
|
animals, newborn |
9 |
|
anisotropy |
9 |
|
anti-bacterial agents - pharmacology |
9 |
|
behavior change |
9 |
|
body height |
9 |
|
carrier proteins - genetics |
9 |
|
cell differentiation - drug effects |
9 |
|
clustering |
9 |
|
cohort study |
9 |
|
cross reactions |
9 |
|
diarrhoea |
9 |
|
disease surveillance |
9 |
|
dna-binding proteins - genetics |
9 |
|
european continental ancestry group |
9 |
|
exercise |
9 |
|
gene deletion |
9 |
|
germ cells |
9 |
|
haplotype |
9 |
|
heart - physiology |
9 |
|
hong kong genome project |
9 |
|
il-10 |
9 |
|
immunoglobulin g - blood |
9 |
|
injury |
9 |
|
intradermal |
9 |
|
isolation |
9 |
|
longitudinal studies |
9 |
|
markov chains |
9 |
|
maternal |
9 |
|
mobile game |
9 |
|
molecular epidemiology |
9 |
|
monte carlo method |
9 |
|
nasopharynx - virology |
9 |
|
neuromuscular diseases |
9 |
|
neurotoxicity syndromes |
9 |
|
pedigree |
9 |
|
pharmacovigilance |
9 |
|
preschooler |
9 |
|
radiotherapy |
9 |
|
relapse |
9 |
|
serum 25-hydroxyvitamin d |
9 |
|
severe acute respiratory syndrome - blood - epidemiology |
9 |
|
sex factors |
9 |
|
sleep |
9 |
|
surveillance |
9 |
|
survival rate |
9 |
|
travel history |
9 |
|
urine - virology |
9 |
|
vaccine safety |
9 |
|
wiskott-aldrich syndrome |
9 |
|
abdominal pain |
8 |
|
adhd |
8 |
|
age distribution |
8 |
|
aged, 80 and over |
8 |
|
allergology and immunology |
8 |
|
antiviral agents - therapeutic use |
8 |
|
baby-friendly hospital initiative |
8 |
|
bacteria |
8 |
|
bintrafusp alfa |
8 |
|
biological markers |
8 |
|
bnt162b2 mrna covid-19 vaccines |
8 |
|
cell movement - drug effects |
8 |
|
chemotherapy |
8 |
|
child abuse |
8 |
|
child abuse and neglect |
8 |
|
chromatography, high pressure liquid |
8 |
|
community |
8 |
|
coronavirus - classification - genetics - isolation & purification |
8 |
|
coronavirus infections - epidemiology - physiopathology - virology |
8 |
|
correlative biomarkers |
8 |
|
coughing |
8 |
|
covid-19 pandemic |
8 |
|
covid‐19 |
8 |
|
cyclin a2 |
8 |
|
diarrhea |
8 |
|
disease predisposition |
8 |
|
dna - genetics |
8 |
|
drug regulatory |
8 |
|
duchenne muscular dystrophy |
8 |
|
dysmorphism |
8 |
|
effectiveness |
8 |
|
embryonic stem cell |
8 |
|
embryonic stem cells - cytology - drug effects - transplantation |
8 |
|
embryonic stem cells - cytology - metabolism |
8 |
|
evolution, molecular |
8 |
|
exons - genetics |
8 |
|
family hardship |
8 |
|
family health |
8 |
|
ferric compounds - adverse effects |
8 |
|
founder mutation |
8 |
|
gastroenteritis |
8 |
|
gene transfer |
8 |
|
green fluorescent proteins - analysis - biosynthesis |
8 |
|
hbv integration |
8 |
|
health disparity |
8 |
|
health equity |
8 |
|
hypercytokinemia |
8 |
|
hyperinsulinism |
8 |
|
immunogenicity |
8 |
|
in situ hybridization, fluorescence |
8 |
|
inactivated vaccine |
8 |
|
inborn errors of immunity |
8 |
|
infection control |
8 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
|
influenza vaccine |
8 |
|
injury prevention |
8 |
|
kir genetics |
8 |
|
lymphocyte activation |
8 |
|
lytic cycle |
8 |
|
management |
8 |
|
mice, knockout |
8 |
|
mobile phone |
8 |
|
model |
8 |
|
mrna vaccine |
8 |
|
myocytes, cardiac - cytology - drug effects |
8 |
|
nanoparticles - adverse effects |
8 |
|
nanopore sequencing |
8 |
|
nasopharynx - microbiology |
8 |
|
nose - virology |
8 |
|
nsp1 |
8 |
|
offspring |
8 |
|
oncology medical sciences |
8 |
|
orphan drug policy |
8 |
|
paediatric gastroenterology |
8 |
|
parents |
8 |
|
pediatric population |
8 |
|
phenotyping |
8 |
|
polymerase chain reaction - methods |
8 |
|
post-covid-19 condition |
8 |
|
predictive value of tests |
8 |
|
prenatal diagnosis |
8 |
|
prenatal exome |
8 |
|
probability |
8 |
|
protection |
8 |
|
recombination, genetic |
8 |
|
recurrent or metastatic nasopharyngeal cancer |
8 |
|
respiratory system - virology |
8 |
|
respiratory tract infections |
8 |
|
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
|
rhinitis |
8 |
|
risk stratification |
8 |
|
rt‐pcr |
8 |
|
sars‐cov‐2 |
8 |
|
seizures, febrile - epidemiology |
8 |
|
sequence analysis, dna |
8 |
|
serial |
8 |
|
sex knowledge |
8 |
|
sexual risk behaviors |
8 |
|
sexually transmitted infections |
8 |
|
sleep duration |
8 |
|
splicing |
8 |
|
staining and labeling - methods |
8 |
|
stakeholders |
8 |
|
streptococcus pneumoniae |
8 |
|
structural equation modeling |
8 |
|
superparamagnetic iron oxide |
8 |
|
symptom burden |
8 |
|
thalassemia |
8 |
|
tissue engineering |
8 |
|
transcription, genetic |
8 |
|
translation to patients |
8 |
|
treatment access |
8 |
|
tspyl2 |
8 |
|
urine |
8 |
|
vaccine-related myocarditis |
8 |
|
variants of unknown clinical significance |
8 |
|
ventricular remodeling |
8 |
|
viral load - physiology |
8 |
|
virus cultivation |
8 |
|
virus shedding |
8 |
|
well-being |
8 |
|
youth sexuality |
8 |
|
2009 h1n1 influenza |
7 |
|
action potential |
7 |
|
adaptive immunity |
7 |
|
animal cell |
7 |
|
anoxia - metabolism |
7 |
|
antibody titer |
7 |
|
antigen presentation |
7 |
|
antigens, cd11b - genetics |
7 |
|
antigens, differentiation - biosynthesis |
7 |
|
antimutagenic agents - pharmacology |
7 |
|
antiviral agents - administration and dosage - therapeutic use |
7 |
|
application |
7 |
|
arrhythmias, cardiac - etiology |
7 |
|
asian continental ancestry group - ethnology - genetics |
7 |
|
autoantibodies |
7 |
|
b-lymphocytes - immunology |
7 |
|
baby-friendly |
7 |
|
baby-friendly community initiative |
7 |
|
baby-friendly initiative |
7 |
|
behavior |
7 |
|
biomarkers |
7 |
|
bnt162b2 vaccine |
7 |
|
bocavirus - classification - genetics - isolation & purification |
7 |
|
body mass index |
7 |
|
bone marrow transplantation - adverse effects |
7 |
|
calcium - metabolism |
7 |
|
cancer |
7 |
|
cardiac |
7 |
|
cardiac infection |
7 |
|
cardiovascular health |
7 |
|
carrier state - microbiology |
7 |
|
case report |
7 |
|
cell proliferation |
7 |
|
cervical screening |
7 |
|
child behaviour |
7 |
|
child psychiatry |
7 |
|
cobalt - pharmacology |
7 |
|
codon, nonsense |
7 |
|
comm child health |
7 |
|
common cold - virology |
7 |
|
comorbidity |
7 |
|
cord blood transplantation |
7 |
|
coronavirus - immunology |
7 |
|
coronavirus infections - virology |
7 |
|
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
|
cytokines - biosynthesis - genetics |
7 |
|
development |
7 |
|
disease susceptibility |
7 |
|
dna fingerprinting |
7 |
|
dna, complementary - genetics |
7 |
|
drug resistance, bacterial |
7 |
|
early childhood exposure |
7 |
|
early-life activities |
7 |
|
ebv |
7 |
|
echocardiography |
7 |
|
elder abuse |
7 |
|
embryonic stem cells - transplantation |
7 |
|
enzyme-linked immunosorbent assay |
7 |
|
epidemiology, molecular |
7 |
|
epistasis |
7 |
|
epstein–barr virus |
7 |
|
ets1 |
7 |
|
exome |
7 |
|
family financial pressure |
7 |
|
family functioning |
7 |
|
family-based behavioral intervention |
7 |
|
fetal blood |
7 |
|
fish |
7 |
|
friendly communities |
7 |
|
gastroenteritis - epidemiology - physiopathology - virology |
7 |
|
genome, viral |
7 |
|
genomic diversity |
7 |
|
glycosylation |
7 |
|
graft survival |
7 |
|
graft-versus-host disease |
7 |
|
health disparities |
7 |
|
health inequalities |
7 |
|
healthy eating |
7 |
|
histocompatibility testing |
7 |
|
homeostasis - drug effects |
7 |
|
hpv vaccination |
7 |
|
human leukocyte antigen |
7 |
|
hypertension |
7 |
|
hypoxia inducible factor-1α |
7 |
|
hypoxia-inducible factor 1, alpha subunit - biosynthesis |
7 |
|
il-17 |
7 |
|
immune thrombocytopenia |
7 |
|
immunological profiles |
7 |
|
influenza a virus - immunology |
7 |
|
influenza a virus - isolation & purification |
7 |
|
influenza a virus, h1n1 subtype - genetics |
7 |
|
influenza vaccines - administration & dosage - immunology |
7 |
|
influenza, human - drug therapy - epidemiology - virology |
7 |
|
intimate partner abuse |
7 |
|
intimate partner violence |
7 |
|
leukocytes, mononuclear - virology |
7 |
|
long read genome sequencing |
7 |
|
low-income |
7 |
|
lupus erythematosus |
7 |
|
lupus erythematosus, systemic - ethnology - genetics |
7 |
|
lupus erythematosus, systemic - ethnology - immunology |
7 |
|
macrophages |
7 |
|
mhealth |
7 |
|
mice, transgenic |
7 |
|
microencapsulation |
7 |
|
microrna |
7 |
|
microspheres |
7 |
|
mobile app |
7 |
|
mother |
7 |
|
multigene family |
7 |
|
myelosuppression |
7 |
|
myocardium - cytology - metabolism |
7 |
|
myocardium - metabolism |
7 |
|
myocytes, cardiac - cytology - metabolism |
7 |
|
myocytes, cardiac - transplantation |
7 |
|
nephritis - ethnology - genetics |
7 |
|
organ specificity - drug effects |
7 |
|
oseltamivir - administration and dosage - therapeutic use |
7 |
|
paediatric |
7 |
|
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
|
placebos - administration & dosage |
7 |
|
pluripotent stem cells |
7 |
|
population-based genome project |
7 |
|
precision medicine |
7 |
|
prematurity |
7 |
|
prevention |
7 |
|
protein-serine-threonine kinases - genetics |
7 |
|
psychosocial development |
7 |
|
registries |
7 |
|
respiratory syncytial viruses - isolation & purification |
7 |
|
respiratory tract infections - epidemiology - virology |
7 |
|
reverse transcriptase polymerase chain reaction - methods |
7 |
|
rhinovirus - classification - genetics |
7 |
|
rna, messenger - analysis |
7 |
|
rna, messenger - biosynthesis |
7 |
|
rna, messenger - genetics - metabolism |
7 |
|
saliva |
7 |
|
sarcoplasmic reticulum function |
7 |
|
sars-coronavirus seroprevalence |
7 |
|
school closures |
7 |
|
school-aged children |
7 |
|
self-management |
7 |
|
sequence deletion |
7 |
|
sex distribution |
7 |
|
sexual behaviour |
7 |
|
short read genome sequencing |
7 |
|
snoring |
7 |
|
sodium channel |
7 |
|
statistics as topic |
7 |
|
stem cell transplantation - adverse effects |
7 |
|
stress |
7 |
|
survival analysis |
7 |
|
systemic |
7 |
|
telomere length |
7 |
|
traditional chinese medicine |
7 |
|
transplantation, homologous |
7 |
|
troponin t - biosynthesis |
7 |
|
user-friendly |
7 |
|
vaccination - methods |
7 |
|
vascular endothelial growth factor a - metabolism |
7 |
|
ventricular function |
7 |
|
vitamin d deficiency |
7 |
|
β-thalassemia major |
7 |
|
22q11.2 deletion |
6 |
|
22q11.2 deletion syndrome (22q11.2ds) |
6 |
|
25(oh)d |
6 |
|
acyclovir - therapeutic use |
6 |
|
adolescent development |
6 |
|
agammaglobulinemia |
6 |
|
animal experiment |
6 |
|
animal model |
6 |
|
antibiotic prophylaxis |
6 |
|
antibodies |
6 |
|
antibodies, neutralizing - blood |
6 |
|
apoptosis - immunology |
6 |
|
apoptotic cells |
6 |
|
array comparative genomic hybridization |
6 |
|
autism spectrum disorder (asd) |
6 |
|
autoimmune diseases |
6 |
|
bayes theorem |
6 |
|
benzofurans - pharmacology |
6 |
|
biopsy |
6 |
|
blood |
6 |
|
blood pressure monitoring, ambulatory |
6 |
|
bmi status |
6 |
|
bone loss |
6 |
|
bone marrow aspiration |
6 |
|
bone mineral testing |
6 |
|
carrier proteins - blood - genetics |
6 |
|
carrier state |
6 |
|
caveolins |
6 |
|
cell composition |
6 |
|
cell division |
6 |
|
cell line, tumor |
6 |
|
cell lineage-specific |
6 |
|
cfu-f |
6 |
|
challenge |
6 |
|
child behavior |
6 |
|
child welfare |
6 |
|
china - ethnology |
6 |
|
chinese medicine |
6 |
|
chromosomes, human, pair 1 - genetics |
6 |
|
clinical phenotype |
6 |
|
coculture techniques |
6 |
|
combined modality therapy |
6 |
|
confidence intervals |
6 |
|
conotruncal anomaly |
6 |
|
conservation |
6 |
|
contrast media |
6 |
|
cost-benefit analysis |
6 |
|
cox regression |
6 |
|
cross-cultural comparison |
6 |
|
cytogenetics |
6 |
|
cytoprotection |
6 |
|
cytotoxicity, immunologic |
6 |
|
deep learning |
6 |
|
dendritic cell |
6 |
|
diarrhea - microbiology |
6 |
|
diffusion magnetic resonance imaging |
6 |
|
disease transmission, infectious - statistics & numerical data |
6 |
|
down-regulation |
6 |
|
dysglycaemia |
6 |
|
early child development |
6 |
|
endemic diseases - statistics & numerical data |
6 |
|
enzyme inhibitors - pharmacology |
6 |
|
epicardial patch |
6 |
|
exosomes |
6 |
|
extracellular matrix |
6 |
|
extracellular vesicle |
6 |
|
extracellular vesicles |
6 |
|
family breakfast |
6 |
|
family dinner |
6 |
|
family meal |
6 |
|
family satisfaction |
6 |
|
fasting glucose |
6 |
|
fatty acids |
6 |
|
fecal |
6 |
|
fever - diagnosis |
6 |
|
gastroenteritis - epidemiology - virology |
6 |
|
gastrointestinal diseases - microbiology |
6 |
|
gc gene |
6 |
|
gene expression regulation - drug effects |
6 |
|
genetic risk predisposition |
6 |
|
genetic variation |
6 |
|
gpx3 |
6 |
|
gram-positive bacteria - isolation & purification |
6 |
|
gram-positive bacterial infections - microbiology |
6 |
|
h7n9 |
6 |
|
haploidentical |
6 |
|
hcc |
6 |
|
head and neck neoplasms |
6 |
|
health empowerment |
6 |
|
hemagglutination inhibition tests |
6 |
|
hemagglutinins, viral - immunology |
6 |
|
heptavalent pneumococcal conjugate vaccine |
6 |
|
hipsc-mscs |
6 |
|
histocompatibility antigens class i - analysis |
6 |
|
hiv-1 - pathogenicity |
6 |
|
hong kong chinese |
6 |
|
hong kong/epidemiology |
6 |
|
human induced pluripotent stem cells |
6 |
|
human rhinovirus c |
6 |
|
hypoglycaemia |
6 |
|
il-2 |
6 |
|
image processing, computer-assisted |
6 |
|
immune dysregulation |
6 |
|
immune reconstitution |
6 |
|
immunocompromised host |
6 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
6 |
|
influenza a virus, h1n1 subtype - isolation and purification |
6 |
|
influenza a virus, h1n1 subtype - physiology |
6 |
|
influenza a virus, h5n1 subtype |
6 |
|
influenza a virus, h5n1 subtype - physiology |
6 |
|
influenza a virus, h9n2 subtype - physiology |
6 |
|
influenza b |
6 |
|
influenza, human - complications - diagnosis - epidemiology |
6 |
|
influenza, human - epidemiology - prevention & control - virology |
6 |
|
influenzavirus a - genetics - immunology - pathogenicity |
6 |
|
insulin-like growth factor i - pharmacology |
6 |
|
interleukin 10 |
6 |
|
internal capsule - pathology |
6 |
|
introns - genetics |
6 |
|
intussusception |
6 |
|
karyotype |
6 |
|
karyotyping |
6 |
|
killer cells, natural - immunology |
6 |
|
killer cells, natural - immunology - virology |
6 |
|
killer cells, natural - virology |
6 |
|
kinetics |
6 |
|
lateral ventricles |
6 |
|
leukoencephalopathy |
6 |
|
locomotion |
6 |
|
low income |
6 |
|
mass vaccination |
6 |
|
mental health services |
6 |
|
mesenchymal stromal cell |
6 |
|
metapneumovirus - isolation & purification |
6 |
|
methylationepic |
6 |
|
microbial sensitivity tests |
6 |
|
microbiota |
6 |
|
molecular genetics |
6 |
|
motor performance |
6 |
|
mutation, missense |
6 |
|
myocardial infarction - pathology - physiopathology - surgery |
6 |
|
myocarditis |
6 |
|
natural killer (nk) cell |
6 |
|
necrosis |
6 |
|
neonatal rat |
6 |
|
neurodegeneration |
6 |
|
neurodevelopment |
6 |
|
neurofibromatosis |
6 |
|
nitric oxide |
6 |
|
novel mutation |
6 |
|
oncology |
6 |
|
oral glucose tolerance test |
6 |
|
orthomyxoviridae - immunology - pathogenicity |
6 |
|
orthomyxoviridae - isolation & purification |
6 |
|
outcome |
6 |
|
paediatric-onset |
6 |
|
paramyxoviridae infections - diagnosis - epidemiology - virology |
6 |
|
parkinson's disease |
6 |
|
pediatric cardiology |
6 |
|
peer support |
6 |
|
pericardium - pathology - physiopathology |
6 |
|
pharynx - virology |
6 |
|
picornaviridae infections - epidemiology - virology |
6 |
|
pik3ca |
6 |
|
pneumococcal infections - microbiology |
6 |
|
pneumococcal vaccines |
6 |
|
polycystic ovary syndrome |
6 |
|
polymorphism |
6 |
|
prepulse inhibition |
6 |
|
preschool |
6 |
|
preschoolers |
6 |
|
problematic behaviors |
6 |
|
promoter regions, genetic |
6 |
|
prosthesis implantation - methods |
6 |
|
psychosocial health |
6 |
|
randomized controlled trial |
6 |
|
receptors, antigen, t-cell, gamma-delta - immunology |
6 |
|
regulation |
6 |
|
regulatory t cell |
6 |
|
repressor proteins |
6 |
|
respiratory syncytial virus infections - diagnosis - epidemiology - virology |
6 |
|
respiratory tract infections - diagnosis - epidemiology - virology |
6 |
|
retrospective cohort |
6 |
|
rhinovirus - classification - genetics - isolation and purification |
6 |
|
rickets |
6 |
|
rna, viral - genetics |
6 |
|
rna, viral - genetics - isolation & purification |
6 |
|
ryanodine receptor |
6 |
|
sars virus - immunology - isolation & purification |
6 |
|
sequence alignment |
6 |
|
serotyping |
6 |
|
severe combined immunodeficiency |
6 |
|
sex characteristics |
6 |
|
short stature |
6 |
|
small for gestational age |
6 |
|
social movement |
6 |
|
spinal muscular atrophy |
6 |
|
stat4 transcription factor - genetics |
6 |
|
streptococcus pneumoniae - drug effects - immunology |
6 |
|
streptococcus pneumoniae - immunology |
6 |
|
susceptibility |
6 |
|
t cell epitope |
6 |
|
t-lymphocyte subsets - immunology |
6 |
|
t-lymphocytes - immunology - metabolism |
6 |
|
tetralogy of fallot |
6 |
|
th1 cells - immunology |
6 |
|
thalassaemia |
6 |
|
tissue donors |
6 |
|
transcription factor |
6 |
|
translocation, genetic |
6 |
|
tumor |
6 |
|
tumor microenvironment |
6 |
|
tumor necrosis factor-alpha - biosynthesis |
6 |
|
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
|
tumor suppressor gene |
6 |
|
type i interferon |
6 |
|
vaccine side effect |
6 |
|
vaccine-induced myocarditis |
6 |
|
vaccines, conjugate |
6 |
|
vaccines, inactivated - administration & dosage - immunology |
6 |
|
variant prioritization |
6 |
|
vdr gene |
6 |
|
ventricular dysfunction, left - physiopathology - surgery |
6 |
|
ventricular remodeling - physiology |
6 |
|
virion - immunology |
6 |
|
virus internalization |
6 |
|
vitamin d-binding protein |
6 |
|
γδ t cells |
6 |
|
acute graft-versus-host disease |
5 |
|
acute lymphoblastic leukaemia |
5 |
|
adrenergic effects |
5 |
|
adulthood |
5 |
|
adverse events |
5 |
|
aim2 |
5 |
|
aldosterone synthase deficiency |
5 |
|
alport's syndrome |
5 |
|
alps-like disease |
5 |
|
ampk |
5 |
|
antigens, cd40 - immunology |
5 |
|
antigens, cd56 - metabolism |
5 |
|
antioxidation |
5 |
|
antiviral |
5 |
|
antiviral agents - pharmacology |
5 |
|
arthritis, experimental - etiology - genetics - immunology - pathology |
5 |
|
artificial intelligence |
5 |
|
asia pacific |
5 |
|
astrocytes - metabolism |
5 |
|
autism |
5 |
|
autoimmune diseases - etiology - genetics - immunology |
5 |
|
avian influenza virus (aiv) |
5 |
|
b cells |
5 |
|
b lymphocytes |
5 |
|
b-cell activating factor |
5 |
|
b-cell activation factor receptor |
5 |
|
b-lymphocytes - cytology - immunology |
5 |
|
b-lymphocytes - immunology - metabolism |
5 |
|
b-lymphocytes - immunology - pathology |
5 |
|
bacteremia - complications - epidemiology - etiology |
5 |
|
bacteria - isolation & purification |
5 |
|
beta-thalassemia - blood - immunology - therapy |
5 |
|
bioactivity-guided fractionation |
5 |
|
bioartificial pacemaker |
5 |
|
blindness |
5 |
|
blood platelets - microbiology |
5 |
|
bone marrow transplant |
5 |
|
brain - pathology |
5 |
|
bronchiectasis |
5 |
|
c-type lectins |
5 |
|
calcium signaling |
5 |
|
cancer chemotherapy |
5 |
|
cancer survivors |
5 |
|
cancer treatment |
5 |
|
candida |
5 |
|
cardiac pacing, artificial |
5 |
|
cardiotoxicity |
5 |
|
cd55 |
5 |
|
cd8-positive t-lymphocytes - cytology - immunology |
5 |
|
cell culture techniques - methods |
5 |
|
cell fusion |
5 |
|
cell lineage - immunology |
5 |
|
cell migration |
5 |
|
cell proliferation - drug effects |
5 |
|
cell-free dna |
5 |
|
cerebellum |
5 |
|
cerebral ischemia |
5 |
|
cervical cancer |
5 |
|
chicken |
5 |
|
chicken meat |
5 |
|
child, hospitalized |
5 |
|
childhood lymphoma |
5 |
|
children. |
5 |
|
chlorides - diagnostic use |
5 |
|
chondrocytes - metabolism |
5 |
|
chondroitin sulfate |
5 |
|
chromosomes, human, pair 9 - genetics |
5 |
|
chronic inflammatory demyelinating polyneuropathy |
5 |
|
chronic kidney disease |
5 |
|
clec5a |
5 |
|
clinical article |
5 |
|
clinical genetics and dysmorphology |
5 |
|
clinical trials |
5 |
|
cmv |
5 |
|
cofactors |
5 |
|
collagen - immunology |
5 |
|
communication |
5 |
|
complement |
5 |
|
congenital hypothyroidism |
5 |
|
congenital malformations |
5 |
|
consensus |
5 |